[Chinese expert consensus on the diagnosis and treatment of elderly patients with mantle cell lymphoma (2026)].

Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin lymphoma that predominantly occurs in elderly patients. In China, the proportion of elderly patients with MCL is increasing with the aging of the general population. The emergence of new targeted drugs and novel approaches has changed the treatment patterns and prognosis of MCL. Meanwhile, due to poor tolerance, elderly patients require individualized treatment strategies based on a comprehensive geriatric assessment. Therefore, the Lymphoid Disease Group of the Chinese Society of Hematology, Chinese Medical Association, and the Lymphatic Disease Society of the Chinese Medical Education Association convened relevant experts to formulate this consensus, to improve the diagnosis and treatment levels of elderly patients with MCL in China.